Tavapadon, a drug made by AbbVie to treat Parkinson’s disease, met phase 3 TEMPO-1 trial goals treated early Parkinson's disease and improved motor skills, the company reported on Thursday.
In 1817, a British physician named James Parkinson published An Essay on the Shaking Palsy, describing for the first time ...
Parkinson's disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its progressive nature and debilitating effects on motor function.
Dr. Danielle Larson, Movement Disorders Specialist at Northwestern Medicine, joins Jon Hansen (in for Lisa Dent) to discuss ...
These results back up results from the TEMPO-3 trial, which tested tavapadon as an add-on therapy to levodopa and which also ...
"It's hard to say or predict the future as to whether or not Brett Favre or other folks we maybe know in our community would ...
Brett Favre, former star quarterback for the Green Bay Packers, disclosed Tuesday that he was recently diagnosed with ...
A tremor that won’t stop, slow movements, rigid muscles they’re the classic signs of Parkinson’s disease that alert doctors ...
Parkinson's disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its ...
Brett Favre announced his diagnosis on Tuesday. Here’s what we know about the disease and its relationship to head injuries.
All of a sudden, the health benefits of coffee has become a hot topic. Now comes a new study that suggests people are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback